Prognostic value of IL6 in young adults presenting with acute coronary syndrome
Background: Interest to evaluate the prognostic value of the inflammatory marker, IL-6 in young patients with ACS. Methods: 140 young patients (18–40 years old) with ACS, were included in this non-randomized prospective study. They were subjected to (a) full clinical evaluation (b) Laboratory evalua...
Main Authors: | Ahmed Mowafy, Hazem El-Akabawy, Ashraf Hussein, Ahmed Abd El Hay |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2015-06-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110260814000027 |
Similar Items
-
ROLE OF INTERLEUKIN-6 AND PROCALCITONIN AS INFLAMMATORY BIOMARKERS IN EVALUATING COVID-19 DISEASE SEVERITY ON HRCT CHESTAN EXPERIENCE AT CMH QUETTA
by: Zeeshan Ayub, et al.
Published: (2021-12-01) -
Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
by: Arian Ghassemian, et al.
Published: (2021-01-01) -
Cytokine responses to small sided games in young soccer players
by: Veysel Böge, et al.
Published: (2022-06-01) -
Maternal Serum and Cervicovaginal IL-6 in Patients with Symptoms of Preterm Labor
by: Parisa Yavari Kia, et al.
Published: (2016-09-01) -
Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study
by: Bahram Nikkhoo, et al.
Published: (2023-05-01)